bf/NASDAQ:IKNA_icon.jpeg

NASDAQ:IKNA

Ikena Oncology, Inc.

  • Stock

USD

Last Close

1.39

28/03 15:01

Market Cap

64.67M

Beta: 0.75

Volume Today

28.97K

Avg: 63.66K

PE Ratio

−0.98

PFCF: −0.87

  • industry

    Biotechnology
  • exchange

    NASDAQ Global Market
  • website

    ikenaoncology.com
  • ipo date

    Mar 26, 2021
  • full time employees

    80
  • currency

    USD

Ikena Oncology, Inc., a targeted oncology company, focuses on developing medicines tailored to biomarker-defined patient groups for specific unmet needs. Its lead targeted oncology product candidate is IK-930, an oral small molecule inhibitor of the transcriptional enhanced associate domain, transcr...Show More

Earnings

Earnings per Share (Estimate*)

-2.5-2-1.5-1-0.52020-03-312021-05-132022-05-122023-05-152024-05-13

Revenue (Estimate*)

5M10M15M20M2020-03-312021-05-132022-05-122023-05-152024-05-13

*Estimate based on analyst consensus

Please Sign In To Use The Chat

The chat is only available for registered users, please sign in or create your free account.